January 30 - February 1, 2026
The LL&M Winter Symposium is designed to help clinicians bridge the latest 2025 data with the real-world decisions that will shape patient care in 2026. Through focused discussions, expert analysis, and practical case-based exploration, the LL&M Winter Symposium goes beyond presenting new evidence — it breaks it down, contextualizes it, and turns it into clear, actionable strategies you can bring directly into practice.
Explore the comparison below to see how the LL&M Winter Symposium delivers unique value — and why it’s recognized as one of the most practical and clinically relevant hematologic malignancy education programs of the year.
|
Key Features |
LL&M Winter Symposium |
Compared to Other Hematology Meetings |
| Scope of Curriculum | Presents the latest clinical advances in hematologic malignancies (leukemia, lymphoma, myeloma, and CLL) with a focus on synthesizing breaking data and incorporating it into practice. | Many meetings focus primarily on updates or single disease areas without the aggressive emphasis on data-to-practice translation. |
| Educational Format | Combines data-driven presentations, expert-led case studies, interactive Q&A sessions, and networking opportunities to embed insights into clinical workflows. | Other conferences may be more traditional lecture-centric, with less emphasis on immediate translation or interactive elements. |
| Faculty Expertise | Features a broad roster of leading clinical investigators and practicing hematology/oncology specialists whose work spans multiple malignancies and emerging therapies. | Some meetings may have narrower faculty composition (for example, disease-specific or research-only) and less breadth of practical clinical leadership. |
| Timing & Positioning | Serves as an early-year symposium, positioning attendees ahead of the annual conference cycle with up-to-date data and key strategies for the year ahead. | Many hematology meetings are standalone and may occur later in the year, so insights are not always positioned as the first major update of the year. |
| Audience Engagement & Networking | Provides a focused, immersive environment with ample opportunities for peer interaction, networking, and reflection on practice. | Other meetings often take place in more standard conference settings with fewer curated networking opportunities. |
| Practical Takeaways & Integration | Designed to leave attendees with actionable, clinically relevant strategies: how to interpret trial data, integrate novel agents, and adapt to evolving standards of care. | Many meetings provide high-level data overview but offer less focused guidance on implementation in daily practice. |
| Continuity & Educational Ecosystem | Builds on the legacy of LL&M while complementing the flagship Congress and related programs, offering a continuum of hematology education. | Some conferences operate in isolation without explicit links to a broader educational ecosystem. |